Literature DB >> 10760259

Using antibody catalysis to study the outcome of multiple evolutionary trials of a chemical task.

A Karlstrom1, G Zhong, C Rader, N A Larsen, A Heine, R Fuller, B List, F Tanaka, I A Wilson, C F Barbas, R A Lerner.   

Abstract

Catalytic aldolase antibodies generated by immunization with two different, but structurally related, beta-diketone haptens were cloned and sequenced to study similarities and differences between independently evolved catalysts. Kinetic and sequence analysis coupled with mutagenesis, structural, and modeling studies reveal that the defining event in the evolution of these catalysts was a somatic mutation that placed a lysine residue in a deep, yet otherwise unrefined, hydrophobic pocket. We suggest that covalent chemistries may be as readily selected from the immune repertoire as the traditional noncovalent interactions that have formed the basis of immunochemistry until this time. Further, we believe that these experiments recapitulate the defining events in the evolution of nature's enzymes, particularly as they relate to chemical mechanism, catalytic promiscuity, and gene duplication.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10760259      PMCID: PMC18110          DOI: 10.1073/pnas.97.8.3878

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Pseudoallelism and gene evolution.

Authors:  E B LEWIS
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1951

2.  IMGT, the international ImMunoGeneTics database.

Authors:  M P Lefranc; V Giudicelli; C Ginestoux; J Bodmer; W Müller; R Bontrop; M Lemaitre; A Malik; V Barbié; D Chaume
Journal:  Nucleic Acids Res       Date:  1999-01-01       Impact factor: 16.971

3.  Immune versus natural selection: antibody aldolases with enzymic rates but broader scope.

Authors:  C F Barbas; A Heine; G Zhong; T Hoffmann; S Gramatikova; R Björnestedt; B List; J Anderson; E A Stura; I A Wilson; R A Lerner
Journal:  Science       Date:  1997-12-19       Impact factor: 47.728

4.  Structural insights into the evolution of an antibody combining site.

Authors:  G J Wedemayer; P A Patten; L H Wang; P G Schultz; R C Stevens
Journal:  Science       Date:  1997-06-13       Impact factor: 47.728

5.  Product binding and role of the C-terminal region in class I D-fructose 1,6-bisphosphate aldolase.

Authors:  N Blom; J Sygusch
Journal:  Nat Struct Biol       Date:  1997-01

6.  The interplay between binding energy and catalysis in the evolution of a catalytic antibody.

Authors:  H D Ulrich; E Mundorff; B D Santarsiero; E M Driggers; R C Stevens; P G Schultz
Journal:  Nature       Date:  1997-09-18       Impact factor: 49.962

7.  Tertiary templates for proteins. Use of packing criteria in the enumeration of allowed sequences for different structural classes.

Authors:  J W Ponder; F M Richards
Journal:  J Mol Biol       Date:  1987-02-20       Impact factor: 5.469

Review 8.  Enzyme recruitment in evolution of new function.

Authors:  R A Jensen
Journal:  Annu Rev Microbiol       Date:  1976       Impact factor: 15.500

9.  The three-dimensional structure of N-acetylneuraminate lyase from Escherichia coli.

Authors:  T Izard; M C Lawrence; R L Malby; G G Lilley; P M Colman
Journal:  Structure       Date:  1994-05-15       Impact factor: 5.006

10.  Lysine-146 of rabbit muscle aldolase is essential for cleavage and condensation of the C3-C4 bond of fructose 1,6-bis(phosphate).

Authors:  A J Morris; D R Tolan
Journal:  Biochemistry       Date:  1994-10-11       Impact factor: 3.162

View more
  9 in total

1.  Catalytic and binding poly-reactivities shared by two unrelated proteins: The potential role of promiscuity in enzyme evolution.

Authors:  L C James; D S Tawfik
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

2.  One site fits both: a model for the ternary complex of folate + NADPH in R67 dihydrofolate reductase, a D2 symmetric enzyme.

Authors:  E E Howell; U Shukla; S N Hicks; R D Smiley; L A Kuhn; M I Zavodszky
Journal:  J Comput Aided Mol Des       Date:  2001-11       Impact factor: 3.686

3.  Site-Selective Antibody Functionalization via Orthogonally Reactive Arginine and Lysine Residues.

Authors:  Dobeen Hwang; Napon Nilchan; Alex R Nanna; Xiaohai Li; Michael D Cameron; William R Roush; HaJeung Park; Christoph Rader
Journal:  Cell Chem Biol       Date:  2019-06-20       Impact factor: 8.116

4.  Multiple catalytic aldolase antibodies suitable for chemical programming.

Authors:  Rajib Kumar Goswami; Zheng-Zheng Huang; Jane S Forsyth; Brunhilde Felding-Habermann; Subhash C Sinha
Journal:  Bioorg Med Chem Lett       Date:  2009-04-18       Impact factor: 2.823

5.  Instant immunity through chemically programmable vaccination and covalent self-assembly.

Authors:  Mikhail Popkov; Beatriz Gonzalez; Subhash C Sinha; Carlos F Barbas
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

Review 6.  Chemically programmed antibodies.

Authors:  Christoph Rader
Journal:  Trends Biotechnol       Date:  2014-03-11       Impact factor: 19.536

7.  Global profiling of lysine reactivity and ligandability in the human proteome.

Authors:  Stephan M Hacker; Keriann M Backus; Michael R Lazear; Stefano Forli; Bruno E Correia; Benjamin F Cravatt
Journal:  Nat Chem       Date:  2017-07-31       Impact factor: 24.427

8.  Routes to covalent catalysis by reactive selection for nascent protein nucleophiles.

Authors:  Andrey V Reshetnyak; Maria Francesca Armentano; Natalia A Ponomarenko; Domenica Vizzuso; Oxana M Durova; Rustam Ziganshin; Marina Serebryakova; Vadim Govorun; Gennady Gololobov; Herbert C Morse; Alain Friboulet; Sudesh P Makker; Alexander G Gabibov; Alfonso Tramontano
Journal:  J Am Chem Soc       Date:  2007-11-29       Impact factor: 15.419

9.  An Engineered Arginine Residue of Unusual pH-Sensitive Reactivity Facilitates Site-Selective Antibody Conjugation.

Authors:  Napon Nilchan; James M Alburger; William R Roush; Christoph Rader
Journal:  Biochemistry       Date:  2021-03-23       Impact factor: 3.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.